A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

SUBMITTER: Moreno-Gonzalez G 

PROVIDER: S-EPMC7862837 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature